A detailed history of Pnc Financial Services Group, Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 44 shares of MDXG stock, worth $398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 38 15.79%
Holding current value
$398
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$5.65 - $7.76 $33 - $46
6 Added 15.79%
44 $0
Q2 2024

Aug 09, 2024

SELL
$6.16 - $8.08 $12,196 - $15,998
-1,980 Reduced 98.12%
38 $0
Q1 2024

May 10, 2024

BUY
$7.61 - $8.63 $45 - $51
6 Added 0.3%
2,018 $15,000
Q4 2023

Feb 09, 2024

BUY
$5.7 - $9.14 $1,624 - $2,604
285 Added 16.5%
2,012 $17,000
Q3 2023

Nov 13, 2023

BUY
$6.35 - $8.16 $1,441 - $1,852
227 Added 15.13%
1,727 $12,000
Q3 2022

Nov 10, 2022

BUY
$2.71 - $4.22 $4,065 - $6,330
1,500 New
1,500 $4,000
Q2 2022

Aug 12, 2022

SELL
$3.17 - $5.0 $289,395 - $456,460
-91,292 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$5.32 - $10.17 $485,673 - $928,439
91,292 New
91,292 $828,000
Q4 2018

Feb 08, 2019

SELL
$1.15 - $6.45 $171,509 - $961,946
-149,139 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$3.22 - $6.33 $72,292 - $142,114
22,451 Added 17.72%
149,139 $0
Q2 2018

Aug 10, 2018

BUY
$5.39 - $8.96 $133,607 - $222,100
24,788 Added 24.33%
126,688 $0
Q1 2018

May 11, 2018

SELL
$6.69 - $17.96 $1,726 - $4,633
-258 Reduced 0.25%
101,900 $0
Q4 2017

Feb 09, 2018

SELL
$10.87 - $13.9 $22,685 - $29,009
-2,087 Reduced 2.0%
102,158 $0
Q3 2017

Nov 13, 2017

BUY
$11.86 - $17.34 $1.24 Million - $1.81 Million
104,245
104,245 $0

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.